期刊文献+

非典型抗精神病药物对精神分裂症患者QTc间期影响的性别差异 被引量:4

Sex Differences in the Effect of Atypical Antipsychoticson QTc Interval in Patients with Schizophrenia
下载PDF
导出
摘要 目的:研究奥氮平、利培酮、阿立哌唑、喹硫平对202例精神分裂症患者QTc影响的性别差异。方法:入组奥氮平组55例,利培酮组51例,阿立哌唑组58例,喹硫平组38例,每例患者均进行心电图检查,同时计算QTc值。结果:四种非典型抗精神病药物组之间QTc间期存在明显差异,方差分析表明喹硫平组的平均QTc间期显著长于利培酮、阿立哌唑组,奥氮平组的平均QTc间期显著长于利培酮组。对女性患者而言,四种抗精神病药物组QTc间期的差异有统计学意义(P<0.05)。然而,男性患者之间比较差异无统计学意义(P>0.05)。在奥氮平组,女性患者的平均QTc要显著长于男性患者(P<0.05),而在其他组则没有明显差异(P>0.05)。结论:与利培酮和阿立哌唑相比,奥氮平、喹硫平对QTc间期的影响更为明显,在女性患者中这种影响更为明显。 Objective: To study sex differences in the effect of olanzapine(OLZ),risperidone(RIS),aripiprazole(ARP),or quetiapine(QTP) on mean corrected QT(QTc) intervals among 202 patients with schizophrenia.Method: Subjects were patients with schizophrenia who were treated with either OLZ(n=55),RIS(n=51),ARP(n=58),or QTP(n=38). Electrocardiographic measurements were conducted,and the QT interval was corrected using Bazett's correction formula. Result: The mean QTc interval of the QTP group was significantly longer than that of the RIS group(P〈0.05) or ARP group(P〈0.05). The mean QTc interval of the OLZ group was also significantly longer than that of the RIS group(P〈0.05).In female participants,the difference in the mean QTc interval among the four second-generation antipsychotic groups was statistically significant(P〈0.05),whereas in male patients,there was no significant difference in the mean QTc interval among the four SGA groups(P〉0.05). Post hoc analyses show that sex differences in QTc interval were observed only in OLZ treatment group(P〈0.05).Conclusion: The OLZ and QTP treatment had a greater impact on the QTc interval compared with RIS or ARP. These effects are evident especially in female participants.
作者 陈丽君 周群
机构地区 南京脑科医院
出处 《中外医学研究》 2014年第36期14-15,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 性别差异 QTC间期 抗精神病药 Sex difference QT interval Antipsychotics
  • 相关文献

参考文献10

  • 1Glassman A H, Jr Bigger J T.Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death[J].Am J Psychiatry, 2001, 158(11): 1774-1782.
  • 2Vieweg W V.New generation antipsychotic drugs and QTc interval prolongation[J].Prim Care Companion J Clin Psychiatry, 2003, 5(5) : 205-215.
  • 3Zemrak W R, Kenna G A.Association of antipsychotic and antidepressant drugs with Q-T interval prolongation[J]. Am J Health Syst Pharm, 2008, 65(11): 1029-1031.
  • 4Harrigan E P, Miceli J Ji Anziano R, et al.A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition[J].J Clin Psychopharmacol, 2004, 24(1) : 62-69.
  • 5Pigott T A, Carson W H, Saha A R, et al.Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo- controlled26-weekstudy[J].JClinPsychiatry, 2003, 64(9): 1048-1056.
  • 6Smetana P, Batchvarov V N, Hnatkova K, et al.Sex differences in repolarization homogeneity and its circadian pattern[J].Am J Physiol Heart CircPhysiol, 2002, 28(2): 1889-1897.
  • 7Yang F D, Wang X Q, Liu X P, et al. Sex difference in QTc prolongation in chronic institutionalized patients with schizophrenia on long-term treatment with typical[J].Am J Physiol Heart Circ Physiol, 2011, 37(5): 189-197.
  • 8Reilly J G, Ayis S A, Ferrier I N, et al.QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients[J].Lancet, 2000, 355(9209): 1048-1052.
  • 9胡君,卢玲.阿立哌唑与奥氮平治疗女性精神分裂症患者的对照研究[J].中国医学创新,2013,10(8):42-44. 被引量:10
  • 10Vieweg W V, Wood M A, Fernandez A, et al.Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly[J]. Drugs Aging, 2009, 26(12): 997-1012.

二级参考文献8

  • 1吴仁容,李乐华.新型抗精神病药:阿立哌唑[J].国外医学(精神病学分册),2004,31(3):177-179. 被引量:380
  • 2张璞,李中东,焦正.第二代非典型抗精神病药——阿立哌唑[J].中国药学杂志,2005,40(3):238-240. 被引量:58
  • 3Hirose T, Uwahodo Y, Yamada S, et al.Efficacy and favorable side- effect rofileof, aripiprazode determined in rat with apomorphine- induced stereotype, catalepsy, and ptosisinduction[J].Int J Neuropsychopharm, 2000, 3 ( Suppl ) : 131-136.
  • 4Marder S R, Mcquade R D, Stock E, et al.Aripiprazole in the treatment of schizophrenia: safaty and tolerability in short-term, placebo- controlled trials[J].Schizophr Res, 2003, 61 ( 6 ) : 123-136.
  • 5Kane J M, Carson W H, Saha A R, et al.Efficacy and safetyof aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder[J].Clin Psychiatry, 2002, 63 (9) : 763-771.
  • 6Inouc A, Seto M, Sugita S, et al.Differential effectson D2 dopaminere-ceptor and prolact in gene expression by haloperidol and aripiprazole in the ratpituitary[J].Brain Res Md Brain Res, 1998, 55 ( 1 ) : 285-292.
  • 7周勇,陈雪芳,林勇,刘勇.阿立哌唑与利培酮治疗精神分裂症对照研究[J].精神医学杂志,2008,21(2):139-140. 被引量:10
  • 8韦安枝,赵兴民,马德荣.阿立哌唑与氯氮平治疗精神分裂症临床对照观察[J].中国医药科学,2011,1(8):85-85. 被引量:13

共引文献9

同被引文献37

引证文献4

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部